FabRx launches M3DIMAKER 3D printer for personalized medicine Medical
FabRx Ltd., a biotech spin-out from University College London (UCL) in the UK, has announced the availability of its M3DIMAKER system, the first pharmaceutical 3D printer developed for the production of customized medicine. The system was first unveiled in Switzerland in September 2019 at the ILMAC Exhibition and now, after extensive testing, it is ready for the market.